[Idiopathic dilated cardiomyopathy--an appraisal in 2005]

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure Management

Context:

• Non-ischemic cardiomyopathy presents a significant risk for sudden cardiac death.
• Standard heart failure therapies may not fully restore left ventricular function.
• Primary prevention strategies are crucial for patients with reduced ejection fraction.

Purpose:

• To outline therapeutic strategies for patients with impaired left ventricular (LV) function of nonischemic origin.
• To determine the optimal timing and indication for implantable cardioverter-defibrillator (ICD) implantation.
• To compare the efficacy of different treatment modalities for ventricular arrhythmias and heart failure.

Summary:

• Patients with LV dysfunction (EF ≤ 35%) should receive intensified heart failure therapy (ACE inhibitors, beta-blockers, diuretics).
• Persistent LV dysfunction after 3-9 months warrants consideration of ICD for primary prevention of sudden cardiac death.
• For non-sustained ventricular tachycardias, ICD and amiodarone show comparable efficacy, superior to heart failure therapy alone. Biventricular ICD is indicated for biventricular pacing needs.

Impact:

• Provides evidence-based guidance for managing non-ischemic heart failure and preventing sudden cardiac death.
• Optimizes treatment selection for patients with ventricular arrhythmias and reduced ejection fraction.
• Highlights the role of advanced therapies like ICDs in improving outcomes for heart failure patients.